by | Jun 7, 2024 | Publications
J Am Pharm Assoc (2003). 2024 Jun 4:102141. doi: 10.1016/j.japh.2024.102141. Online ahead of print. ABSTRACT BACKGROUND: Multiple Myeloma (MM) is a chronic and incurable hematologic malignancy that is prevalent among the elderly. Interprofessional patient care showed...
by | Jun 7, 2024 | Publications
BMJ Case Rep. 2024 Jun 6;17(6):e260061. doi: 10.1136/bcr-2024-260061. ABSTRACT A man in his 40s presented to the emergency department after 2 weeks of abdominal pain and bloating. Radiological investigations revealed multiple unusual sites of thrombosis, including...
by | Jun 7, 2024 | Publications
BMJ Case Rep. 2024 Jun 6;17(6):e257026. doi: 10.1136/bcr-2023-257026. ABSTRACT Multiple myeloma associated with extramedullary plasmacytoma at initial presentation is rare. We describe a case of a man in his 30s who initially presented with symptoms of spinal cord...
by | Jun 6, 2024 | Publications
Blood. 2024 Jun 6;143(23):2344-2345. doi: 10.1182/blood.2024024414. NO ABSTRACT PMID:38842860 | DOI:10.1182/blood.2024024414
by | Jun 6, 2024 | Publications
Cureus. 2024 May 6;16(5):e59732. doi: 10.7759/cureus.59732. eCollection 2024 May. ABSTRACT This case report documents the diagnosis of multiple myeloma (MM) in a 74-year-old man following treatment for locally advanced prostate cancer. It is important to include MM in...
by | Jun 6, 2024 | Publications
Haematologica. 2024 Jun 6. doi: 10.3324/haematol.2024.285534. Online ahead of print. ABSTRACT Carfilzomib, lenalidomide, and dexamethasone (KRd) combination therapy improves the survival of patients with relapsed and/or refractory multiple myeloma (RRMM). Nonetheless,...
